Clinical Trial: Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line
Study Status: Completed
Recruit Status: Completed
Condition: Chronic Myeloid Leukemia
Study Type: Observational
Official Title: Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line - a Non-interventional Study on the Assessment of Deep Molecular Response in CML Patients in Daily Routine.
Brief Summary:
This is a non-interventional observational study within the routine chronic myeloid leukemia treatment practice; no further tests were required apart from the assessments routinely performed for Chronic myeloid leukemia patients treated with nilotinib.
Read more